United States

People: Alexion Pharmaceuticals Inc (ALXN.O)

ALXN.O on Nasdaq

2 Dec 2016
Change (% chg)

$0.95 (+0.78%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sinha, Vikas 

Mr. Vikas Sinha, CPA, is Chief Financial Officer, Executive Vice President of Alexion Pharmaceuticals, Inc. He has been with Alexion since September 2005 and has served as Alexion's Executive Vice President and Chief Financial Officer since October 2012. From September 2005 to October 2012, Mr. Sinha was Senior Vice President and Chief Financial Officer. Prior to joining Alexion, Mr. Sinha held various positions with Bayer AG in the United States, Japan, Germany, and Canada, including Vice President and Chief Financial Officer of Bayer Pharmaceuticals Corporation, USA, Vice President and Chief Financial Officer of Bayer Yakuhin Ltd., in Japan, and Manager, Mergers and Acquisitions with Bayer AG in Germany. He also was a member of the Pharmaceutical Management Committee for North America. Prior to Bayer, Mr. Sinha held several positions of increasing responsibilities with ANZ Bank and Citibank in South Asia. Mr. Sinha holds a Masters of Business Administration from the Asian Institute of Management which included an exchange program with the University of Western Ontario (Richard Ivey School of Business). He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States.

Basic Compensation

Total Annual Compensation, USD 720,000
Restricted Stock Awards, USD 1,907,740
Long-Term Incentive Plans, USD --
All Other, USD 2,108,720
Fiscal Year Total, USD 4,736,450

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 130,000 23,095,400.00
Name Fiscal Year Total

Leonard Bell


David Hallal


Vikas Sinha


Clare Carmichael


John Moriarty


Saqib Islam

As Of  30 Dec 2015